A clinician-administered severity rating scale for illness anxiety: Development, reliability, and validity of the H-YBOCS-M

Depression and Anxiety

Volumn 29, Issue 7, 2012, Pages 652-664

  Skritskaya, Natalia A ^a   Carson Wong, Amanda R ^b   Moeller, James R ^c   Shen, Sa ^c   Barsky, Arthur J ^d,e   Fallon, Brian A ^c,f  

^a Department of Medicine   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c Harvard Medical School ^*  (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

anxiety; anxiety disorders; assessment; diagnosis; health services; hypochondriasis; illness anxiety; measurement; obsessive compulsive disorder (OCD); psychometrics

Indexed keywords

ADULT; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR CONTROL; COMPULSION; CONSTRUCT VALIDITY; CONTROLLED STUDY; DEPRESSION; DISCRIMINANT VALIDITY; DISEASE SEVERITY; DISTRESS SYNDROME; DSM-IV; FEMALE; FUNCTIONAL STATUS; HELP SEEKING BEHAVIOR; HUMAN; HYPOCHONDRIASIS; HYPOCHONDRIASIS Y BOCS; INTERNAL CONSISTENCY; INTERRATER RELIABILITY; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; SENSITIVITY ANALYSIS; SOMATIZATION; TEST RETEST RELIABILITY; TREATMENT RESPONSE;

ADULT; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; HYPOCHONDRIASIS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS;

EID: 84863435863     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.21949     Document Type: Article

References (34)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text revision. Washington, DC: American Psychiatric Association; 2000.
2. Barsky AJ, Ettner SL, Horsky J, Bates DW,. Resource utilization of patients with hypochondriacal health anxiety and somatization. Med Care 2001; 39: 705-715. (Pubitemid 33610095)
3. Hansen MS, Fink P, Sondergaard L, Frydenberg M,. Mental illness and health care use: a study among new neurological patients. Gen Hosp Psychiatry 2005; 27: 119-124. (Pubitemid 40348776)
4. Barsky AJ, Wyshak G, Klerman GL, Latham KS,. The prevalence of hypochondriasis in medical outpatients. Soc Psychiatry Psychiatr Epidemiol 1990; 25: 89-94. (Pubitemid 20163988)
5. Barsky AJ, Ahern DK,. Cognitive behavior therapy for hypochondriasis. JAMA 2004; 291: 1464-1470.
6. Greeven A, van Balkom AJLM, Visser S, et al. Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial. Am J Psychiatry 2007; 164: 91-99. (Pubitemid 46154786)
7. Fallon BA, Petkova E, Skritskaya N, et al. A double-masked, placebo-controlled study of fluoxetine for hypochondriasis. J Clin Psychopharmacol 2008; 28: 638-645.
8. Thomson AB, Page LA,. Psychotherapies for hypochondriasis. Cochrane Database Syst Rev 2007; 4: 1-35.
9. Pilowsky I,. Dimensions of hypochondriasis. Br J Psychiatry 1967; 113: 89-93.
10. Kellner R,. Abridged Manual of the Illness Attitude Scales (Mimeographed). Albuquerque, NM: University of New Mexico Press, 1987.
11. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale: I. Development, use and reliability. Arch Gen Psychiatry 1989; 46: 1006-1011. (Pubitemid 19278229)
12. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale: II. Validity. Arch Gen Psychiatry 1989; 46: 1012-1016. (Pubitemid 19278230)
13. Phillips KA, Hollander E, Rasmussen SA, et al. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive-Compulsive Scale. Psychopharmacol Bull 1997; 33: 17-22. (Pubitemid 27184190)
14. Greeven A, Spinhoven P, van Balkom AJLM,. Hypochondriasis Y-BOCS: a study of the psychometric properties of a clinician-administered semi-structured interview to assess hypochondriacal thoughts and behaviors. Clin Psychol Psychotherapy 2009; 16 (5): 431-443.
15. Fallon BA, Javitch JA, Hollander E, Liebowitz MR,. Hypochondriasis and obsessive compulsive disorder: overlaps in diagnosis and treatment. J Clin Psychiatry 1991; 52: 457-460.
16. Greeven A, van Balkom AJ, van Rood YR, et al. The boundary between hypochondriasis and obsessive-compulsive disorder: a cross-sectional study from the Netherlands. J Clin Psychiatry 2006; 67 (11): 1682-1689. (Pubitemid 44955147)
17. American Psychiatric Association. DSM-V Development. J 02 Illness Anxiety Disorder. Available at:. Accessed November 19, 2011.
18. Barsky AJ, Cleary PD, Wyshak G, et al. A Structured Diagnostic Interview for Hypochondriasis: a proposed criterion standard. J NervMent Dis 1992; 180: 20-27.
19. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (Suppl 20): 22-33;quiz 34-57. (Pubitemid 29001829)
20. Fallon BA,. Pharmacologic strategies for hypochondriasis. In:, Starcevic V, Lipsett DR, editors. Hypochondriasis: Modern Perspectives on an Ancient Malady. Oxford University Press: New York; 2001: 329-368.
21. Kroenke K, Spitzer RL, Williams JBW,. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002; 648: 258-266. (Pubitemid 34260463)
22. Barsky AJ, Wyshak G, Klerman GL,. The Somatosensory Amplification Scale and its relationship to hypochondriasis. J Psychiatr Res 1990; 24 (4): 323-334.
23. Interian A, Allen LA, Gara MA, et al. Somatic complaints in primary care: further examining the validity of the Patient Health Questionnaire (PHQ-15). Psychosomatics 2006; 47: 392-398.
24. Beck AT, Steer RA, Brown GK,. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.
25. Spielberger CD,. Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto, CA: Consulting Psychologists Press; 1983.
26. Endicott J, Nee J, Harrison W, Blumenthal R,. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993; 29: 321-326. (Pubitemid 23311543)
27. Bergner M, Bobbit RA, Carter WB, Gilson BS,. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19 (8): 787-805. (Pubitemid 11021288)
28. Hu L, Bentler PM,. Cut-score criteria for fit indices in covariance structure analysis: conventional criteria versus new alternatives. Structural Equation Modeling 1999; 6: 1-55.
29. Storch EA, Rasmussen SA, Price LH, et al. Development and psychometric evaluation of the Yale-Brown Obsessive-Compulsive Scale-second edition. Psychol Assessment 2010; 22: 223-232.
30. Warwick HMC, Salkovskis PM,. Hypochondriasis. Behav Res Ther 1990; 28: 105-117. (Pubitemid 20145828)
31. Fink P, Ornbol E, Toft T, et al. A new, empirically established hypochondriasis diagnosis. Am J Psychiatry 2004; 161: 1680-1691. (Pubitemid 39201467)
32. Kroenke K, Sharpe M, Sykes R,. Revising the classification of somatoform disorders: key questions and preliminary recommendations. Psychosomatics 2007; 48: 277-285. (Pubitemid 47001259)
33. Neziroglu F, McKay D, Yaryura-Tobias J,. Overlapping and distinctive features of hypochondriasis and obsessive-compulsive disorder. J Anxiety Disord 2000; 14: 603-614. (Pubitemid 32012517)
34. Fallon BA, Qureshi AI, Laje G, Klein B,. Hypochondriasis and its relationship to obsessive-compulsive disorder. Psychiatr Clin North Am 2000; 23: 605-616. (Pubitemid 30666509)